GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » ROC (Joel Greenblatt) %

EZZ Life Science Holdings (ASX:EZZ) ROC (Joel Greenblatt) % : 152.51% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. EZZ Life Science Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 152.51%.

The historical rank and industry rank for EZZ Life Science Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:

ASX:EZZ' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 182.6   Med: 476.33   Max: 492.03
Current: 199.83

During the past 4 years, EZZ Life Science Holdings's highest ROC (Joel Greenblatt) % was 492.03%. The lowest was 182.60%. And the median was 476.33%.

ASX:EZZ's ROC (Joel Greenblatt) % is ranked better than
97.33% of 1458 companies
in the Biotechnology industry
Industry Median: -322.43 vs ASX:EZZ: 199.83

EZZ Life Science Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


EZZ Life Science Holdings ROC (Joel Greenblatt) % Historical Data

The historical data trend for EZZ Life Science Holdings's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings ROC (Joel Greenblatt) % Chart

EZZ Life Science Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23
ROC (Joel Greenblatt) %
- 492.03 182.60 476.33

EZZ Life Science Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial 24.11 356.20 182.39 305.37 152.51

Competitive Comparison of EZZ Life Science Holdings's ROC (Joel Greenblatt) %

For the Biotechnology subindustry, EZZ Life Science Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EZZ Life Science Holdings's ROC (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EZZ Life Science Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where EZZ Life Science Holdings's ROC (Joel Greenblatt) % falls into.



EZZ Life Science Holdings ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.317 + 0.847 + 0.94) - (2.206 + 0.293 + 0.081)
=0.524

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.277 + 1.559 + 2.137) - (4.401 + 0.219 + 0.074999999999999)
=2.278

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of EZZ Life Science Holdings for the quarter that ended in Dec. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3.08/( ( (0.604 + max(0.524, 0)) + (0.633 + max(2.278, 0)) )/ 2 )
=3.08/( ( 1.128 + 2.911 )/ 2 )
=3.08/2.0195
=152.51 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EZZ Life Science Holdings  (ASX:EZZ) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


EZZ Life Science Holdings ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


EZZ Life Science Holdings (ASX:EZZ) Business Description

Traded in Other Exchanges
N/A
Address
104 Derby Street, Silverwater, NSW, AUS, 2128
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines